Entrada Therapeutics Competitors and Similar CompaniesClear all
Entrada Therapeutics's competitors and similar companies include Immatics, Navega Therapeutics, Neopharmed Gentili and CuraVac.
 Entrada Therapeutics Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Navega Therapeutics Navega Therapeutics is a preclinical stage company aimed to treat chronic pain and tackle the opioid epidemic. |  CuraVac CuraVac is a biopharmaceutical company focused on the development of immunotherapies for treating autoimmune and inflammatory diseases including myasthenia gravis (MG), multiple sclerosis (MS), etc. | ||
Founding Date | Founding Date 2016 | Founding Date N/A | Founding Date 2018 | Founding Date 2018 | Founding Date 2002 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations San Diego, US HQ | Locations Milano, IT HQ | Locations Wilmington, US HQ Rixensart, BE |
Employees | Employees 18315% increase | Employees 29723% increase | Employees 10 | Employees 428 | Employees 717% increase |
Valuation ($) | Valuation ($) 642.8 m | Valuation ($) 1.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $25.4m (FY, 2025) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($143.8m) (FY, 2025) | Net income (€196.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 175.6m | Total funding raised $ 267.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companyNavega Therapeutics
HQ
San Diego, US
Employees
10
Navega Therapeutics is a preclinical stage company aimed to treat chronic pain and tackle the opioid epidemic.
View company
Neopharmed Gentili
HQ
Milano, IT
Employees
428
Neopharmed Gentili is a pharmaceutical company.
View companyCuraVac
HQ
Wilmington, US
Employees
7↑ 17% increase
CuraVac is a biopharmaceutical company focused on the development of immunotherapies for treating autoimmune and inflammatory diseases including myasthenia gravis (MG), multiple sclerosis (MS), etc.
View company